Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial

Deceases in Acute Heart Failure Hospitalizations during COVID‐19

(2020) Zachary L Cox et al.   EUROPEAN JOURNAL OF HEART FAILURE

Reductions in Heart Failure Hospitalizations During the COVID-19 Pandemic

(2020) MICHAEL E. HALL et al.   JOURNAL OF CARDIAC FAILURE

Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure

(2020) David M. Shavelle et al.   Circulation-Heart Failure

Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

(2020) Stefan D Anker et al.   EUROPEAN HEART JOURNAL

Pulmonary artery pressure‐guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS E uropean M onitoring S tudy for H eart F ailure ( MEMS‐HF )

(2020) Christiane E. Angermann et al.   EUROPEAN JOURNAL OF HEART FAILURE

Clinical Characteristics and Trends in Heart Failure Hospitalizations: An Australian Experience during the COVID-19 Lockdown

(2020) Liam Toner et al.   JACC-Heart Failure

Impact of coronavirus disease 2019 (COVID-19) outbreak on acute admissions at the emergency and cardiology departments across Europe

(2020) Mateusz Sokolski et al.   AMERICAN JOURNAL OF MEDICINE

Temporal trends in decompensated heart failure and outcomes during COVID ‐19: a multisite report from heart failure referral centres in London

(2020) Antonio Cannatà et al.   EUROPEAN JOURNAL OF HEART FAILURE

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

(2020) Milton Packer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes

(2020) William T Abraham et al.   EUROPEAN HEART JOURNAL

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

(2020) Piotr Ponikowski et al.   LANCET

Hemodynamic-GUIDEd management of Heart Failure (GUIDE-HF)

(2019) JoAnn Lindenfeld et al.   AMERICAN HEART JOURNAL

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial

(2019) Michael E. Nassif et al.   CIRCULATION

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

(2019) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

(2019) Scott D. Solomon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction

(2017) Michael M. Givertz et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Implantable Hemodynamic Monitoring for Heart Failure Patients

(2017) William T. Abraham et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial

(2016) William T Abraham et al.   LANCET

The Prevention of Hospital Readmissions in Heart Failure

(2016) Boback Ziaeian et al.   PROGRESS IN CARDIOVASCULAR DISEASES

Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial

(2011) William T Abraham et al.   LANCET

Chronic Ambulatory Intracardiac Pressures and Future Heart Failure Events

(2010) Lynne Warner Stevenson et al.   Circulation-Heart Failure

Transition From Chronic Compensated to Acute Decompensated Heart Failure

(2008) Michael R. Zile et al.   CIRCULATION

Randomized Controlled Trial of an Implantable Continuous Hemodynamic Monitor in Patients With Advanced Heart Failure

(2008) Robert C. Bourge et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY